These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32175109)

  • 1. Downstaging unresectable hepatocellular carcinoma by radioembolization using 90-yttrium resin microspheres: a single center experience.
    Tabone M; Calvo A; Russolillo N; Langella S; Carbonatto P; Lo Tesoriere R; Richetta E; Pellerito R; Ferrero A
    J Gastrointest Oncol; 2020 Feb; 11(1):84-90. PubMed ID: 32175109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.
    Iñarrairaegui M; Pardo F; Bilbao JI; Rotellar F; Benito A; D'Avola D; Herrero JI; Rodriguez M; Martí P; Zozaya G; Dominguez I; Quiroga J; Sangro B
    Eur J Surg Oncol; 2012 Jul; 38(7):594-601. PubMed ID: 22440743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma.
    Yu CY; Huang PH; Tsang LL; Hsu HW; Lim WX; Weng CC; Huang TL; Hsu CC; Chen CL; Ou HY; Cheng YF
    J Hepatocell Carcinoma; 2023; 10():17-26. PubMed ID: 36660410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective internal radiation therapy with yttrium-90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma.
    Feng X; Zhang L; Niu H; Zhang H; Yang L; Wen Y; Chen SY; Shi Y; He Z; Yu L; Wang Y; Huang X; Wang Z; Qin M; Wen X; Zhang Z; Song J; Zheng Z; Yin H; Zhang H; Ma L; Wei J; Wu X; Zhang L; Zhao Y; Lu Q; Xiao H; Liu T; Fang P; Wei L; Gandhi RT; Dong J
    Asia Pac J Clin Oncol; 2024 Apr; 20(2):319-322. PubMed ID: 36658669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobar hepatocellular carcinoma with ipsilateral portal vein tumor thrombosis treated with yttrium-90 glass microsphere radioembolization: preliminary results.
    Pracht M; Edeline J; Lenoir L; Latournerie M; Mesbah H; Audrain O; Rolland Y; Clément B; Raoul JL; Garin E; Boucher E
    Int J Hepatol; 2013; 2013():827649. PubMed ID: 23476792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis.
    Martelletti C; Ricotti A; Gesualdo M; Carucci P; Gaia S; Rolle E; Burlone ME; Okolicsanyi S; Mattalia A; Pirisi M; Berchialla P; Tabone M
    J Dig Dis; 2021 Aug; 22(8):496-502. PubMed ID: 34189839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial.
    Chauhan N; Bukovcan J; Boucher E; Cosgrove D; Edeline J; Hamilton B; Kulik L; Master F; Salem R
    JMIR Res Protoc; 2018 Aug; 7(8):e11234. PubMed ID: 30111528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
    Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B
    J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.
    Bhangoo MS; Karnani DR; Hein PN; Giap H; Knowles H; Issa C; Steuterman S; Pockros P; Frenette C
    J Gastrointest Oncol; 2015 Oct; 6(5):469-78. PubMed ID: 26487939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
    Wang EA; Stein JP; Bellavia RJ; Broadwell SR
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience.
    Abdelfattah MR; Al-Sebayel M; Broering D; Alsuhaibani H
    Transplant Proc; 2015 Mar; 47(2):408-11. PubMed ID: 25769582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview.
    Sun HC; Zhu XD
    Front Oncol; 2021; 11():772195. PubMed ID: 34869008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization.
    Ibrahim SM; Kulik L; Baker T; Ryu RK; Mulcahy MF; Abecassis M; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1094-101. PubMed ID: 22069121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresectable Intrahepatic Cholangiocarcinoma Treated with Radiation Segmentectomy/Lobectomy Using Yttrium 90-labeled Glass Microspheres.
    Kumar P; Mhaskar R; Kim R; Anaya D; Frakes J; Hoffe S; Choi J; Kis B
    J Clin Exp Hepatol; 2022; 12(5):1259-1263. PubMed ID: 36157145
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Abouchaleh N; Gabr A; Ali R; Al Asadi A; Mora RA; Kallini JR; Mouli S; Riaz A; Lewandowski RJ; Salem R
    J Nucl Med; 2018 Jul; 59(7):1042-1048. PubMed ID: 29217739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
    Wallace MC; Samuelson S; Khoo T; Ooi J; Tibballs J; Ferguson J; Preen DB; Knuiman M; Garas G; MacQuillan G; Adams LA; Jeffrey GP
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1945-1952. PubMed ID: 32036614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: a single centre experience of 45 consecutive patients.
    Saxena A; Meteling B; Kapoor J; Golani S; Danta M; Morris DL; Bester L
    Int J Surg; 2014 Dec; 12(12):1403-8. PubMed ID: 25091398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus.
    Cardarelli-Leite L; Chung J; Klass D; Marquez V; Chou F; Ho S; Walton H; Lim H; Tae Wan Kim P; Hadjivassiliou A; Liu DM
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):411-422. PubMed ID: 31909439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.